Pig stem cell transplants key to future research into retina treatment

A team of American and Chinese scientists studying the role of stem cells in repairing damaged retina tissue have found that pigs represent an effective proxy species to research treatments for humans. The study, published in STEM CELLS, demonstrates how cells can be isolated and transplanted between pigs, overcoming a key barrier to the research.

Treatments to repair the human retina following degenerative diseases remain a challenge for medical science. Unlike species of lower vertebrates the human retina lacks a regenerative pathway meaning that research has focused on cell transplantation.

“The retina is the light sensitive tissue surrounding the inner surface of the eye. Its outer layer is made up of rods and cone photoreceptor cells which convert light signals,” said lead author Douglas Dean from the University of Louisville. “Traditionally transplant studies have focused on mice and other rodents because of the variety of genetic material they represent, however mouse retina tissue is rod dominant, which is significantly different to the human eye.”

Dr Dean’s team turned their attention to pigs because, as with humans, the swine eye contains a cone dominant central visual streak, making it a closer anatomical and physiological match.

“Studies into swine models have been hampered in the past,” said Dean, “because the induced pluripotent stem cells (iPSCs) needed for such transplants have not been isolated from pigs, while their compatibility with a host’s photoreceptor cells had not been demonstrated.”

Dr Dean’s team gathered iPSCs from swine skin fibroblasts and demonstrated that these cells differentiated in culture and could be integrated with the cells of a second pig’s retina.

While only a small section of the retina was transplanted for this study the results could open a new avenue of research into degenerative conditions as researchers have a more effective human proxy species to work with.

“Our results demonstrate that swine stem cells can be integrated into a damaged swine neural retina,” concluded Dean. “This research now lays a foundation for future studies of retinal stem cell transplantation in a swine model.”

This study is published in STEM CELLS.

Full citation: Zhou. L, Wang. W, Liu. Y, Fernandez de Castro. J, Ezashi. T, Telugu. B, Roberts. M, Kaplan. H, Dean. D, “Differentiation of Swine iPSC into Rod Photoreceptors and Their Integration into the Retina”, STEM CELLS, Wiley-Blackwell, DOI: 10.1002/stem.637
URL Upon publication: http://doi.wiley.com/10.1002/stem.637

STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley-Blackwell.
For more information, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1549-4918.

Comments

  1. samy nabil samy nabil Egypt says:

    Hi, i ' ve the same case and i can't see properly at night
    and hope of god and you to get treatment, please contact me soon
    00201225425342
    thnx

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line